Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Nymox Pharmaceutical Corporation
Nymox Annual Report
July 18, 2024
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Tickers
NYMXF
Nymox Required to Resubmit Application to DKMA
July 16, 2024
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Tickers
NYMXF
Nymox Reports Victory in Bahamas Litigation Against Terminated Ex-Employees – Court Awards Costs and Damages
March 27, 2024
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Tickers
NYMXF
Nymox December 27 Message to Shareholders
December 27, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Tickers
NYMXF
Nymox Reports California Court Issues Preliminary Injunction Against Defendants Lanham, Riley, Cutler and Others
November 30, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Tickers
NYMXF
$250 Million Lawsuit Filed Against AscellaHealth by Nymox Accepted and Summons Issued in California Court
November 21, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Tickers
NYMXF
Nymox Pharmaceutical Corporation Sues AscellaHealth For $250 Million
November 09, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Tickers
NYMXF
NYMOX REPORTS: Bahamian Court Today Suspends Order of October 3, 2023 Rendering Riley-Lanham and Accomplices Planned Vote Unauthorized
November 03, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Tickers
NYMXF
NYMOX REPORTS NOTICE: California Court Issued A Temporary Restraining Order Enjoining Lanham, Riley, Cutler And Their Nevada Company After Court Hearing In Santa Ana, California, November 2, 2023
November 03, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Tickers
NYMXF
IMPORTANT MESSAGE TO NYMOX SHAREHOLDERS: NYMOX Cautions Against Unauthorized Improper Shareholder Meeting and Unauthorized Unregistered Solicitations
November 02, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Tickers
NYMXF
IMPORTANT NOTICE: NYMOX Cautions Shareholders Not to Take Calls or Participate in Unauthorized Improper Shareholder Meeting
October 31, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Tickers
NYMXF
Notice: Nymox Informs Its Shareholders Not to Take Calls or Participate in An Unauthorized and Improper Shareholder Meeting
October 27, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Tickers
NYMXF
Nymox Reports New NYMOZARFEX Marketing Application is Accepted For Review
October 26, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Tickers
NYMXF
Nymox Announces Submission of New Marketing Authorization Application Submission for NYMOZARFEX (TM) for BPH
September 25, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Tickers
NYMXF
Nymox Reports Completion of $2 Million Private Placement
August 29, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Tickers
NYMXF
Nymox Announces $2 Million Private Placement
August 02, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Tickers
NYMXF
Nymox's 3-month ex-CFO was Awarded an Unauthorized and Undisclosed Treasury Directive for 100,000 Shares of Nymox Stock Without the Knowledge or Approval of the Nymox Board or Nymox’s CEO
July 31, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Tickers
NYMXF
Nymox Reports Successful New NYMOZARFEX (TM) Long-Term Prostate Cancer Treatment Clinical Trial Results
July 25, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Tickers
NYMX
Nymox Reports on U.S. Patent Issuances
July 18, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Tickers
NYMX
Nymox Update
July 13, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Tickers
NYMX
Nymox Announces Appointment Of Patrick Doody as Vice President and Member of the Board of Directors of Nymox
July 12, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Tickers
NYMX
NYMOX Update
July 07, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Tickers
NYMX
Nymox Delisting from NASDAQ
July 05, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Tickers
NYMX
Nymox Provides Current Update
May 10, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Tickers
NYMX
Nymox Provides Corporate Update
April 03, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Tickers
NYMX
Nymox Announces Appointment of Christopher R. Riley as Chief Financial Officer
March 21, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Tickers
NYMX
Nymox Officially Granted Extension to Regain Listing Requirements
March 15, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Tickers
NYMX
Nymox Announces NYMOZARFEX Marketing Application is Accepted For Review
February 15, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Tickers
NYMX
NYMOX Appeals Deficiency Letter
January 06, 2023
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Tickers
NYMX
NYMOX Announces New Marketing Submission for NYMOZARFEX™ for BPH
December 05, 2022
From
Nymox Pharmaceutical Corporation
Via
GlobeNewswire
Tickers
NYMX
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.